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Upon stimulation by pathogen-associated inflamma-
tory signals, TANK-binding kinase 1 (TBK1) induces
type I interferon expression and modulates nuclear
factor kB (NF-kB) signaling. Here, we describe the
2.4 A˚-resolution crystal structure of nearly full-length
TBK1 in complex with specific inhibitors. The struc-
ture reveals a dimeric assembly created by an
extensive network of interactions among the kinase,
ubiquitin-like, and scaffold/dimerization domains.
An intact TBK1 dimer undergoes K63-linked poly-
ubiquitination on lysines 30 and 401, and these
modifications are required for TBK1 activity. The
ubiquitination sites and dimer contacts are con-
served in the close homolog inhibitor of kB kinase ε
(IKKε) but not in IKKb, a canonical IKK that assem-
bles in an unrelated manner. The multidomain archi-
tecture of TBK1 provides a structural platform for
integrating ubiquitination with kinase activation and
IRF3 phosphorylation. The structure of TBK1 will
facilitate studies of the atypical IKKs in normal and
disease physiology and further the development of
more specific inhibitors that may be useful as anti-
cancer or anti-inflammatory agents.INTRODUCTION
The nuclear factor kB (NF-kB) transcription factors are central
regulators of innate immunity, inflammation, cell proliferation,
and apoptosis (Dolcet et al., 2005; Karin, 2006). Their activity is
tightly regulated through the control of the inhibitor of kB (IkB)
kinase (IKK) family of proteins. The canonical IKK complex
consists of the catalytically active IKKa and IKKb subunits
and the regulatory subunit IKKg/NEMO (Hayden and Ghosh,
2004). In response to stimuli such as cytokines, nondegradativeLys63(K63)-linked and linear (Met1)-linked polyubiquitination
of NEMO results in the activation of the IKKa and IKKb
kinases (Bianchi and Meier, 2009; Tang et al., 2003; Zhou
et al., 2004). These activated kinases phosphorylate the inhib-
itor of NF-kB (IkB) proteins, resulting in their degradative
Lys48(K48)-linked polyubiquitination and subsequent protea-
some-mediated degradation. Upon degradation of the IkB pro-
teins, the NF-kB dimers translocate into the nucleus and activate
the transcription of effector genes that mediate immune and
inflammatory responses and regulate cell survival (Ha¨cker and
Karin, 2006).
In addition to the IKKa and IKKb kinases, two closely related
serine-threonine kinases, TANK-binding kinase (TBK1) and
IKKε, play key distinct roles in innate immune responses to viral
infection and other pathogen-associated inflammatory stimuli by
inducing type I interferon (IFN) expression andmodulatingNF-kB
signaling (Bonnard et al., 2000; Peters et al., 2000; Pomerantz
and Baltimore, 1999; Shimada et al., 1999). TBK1 and IKKε are
found together in a complex and share several binding partners,
including TANK (Chariot et al., 2002; Goncalves et al., 2011),
which facilitates interregulation of the canonical IKKs (Clark
et al., 2011b). TBK1 is constitutively expressed and TBK1-defi-
cent mice exhibit embryonic lethality due to widespread hepatic
apoptosis, a phenotype that closely resembles IKKb-deficient
mice (Bonnard et al., 2000; Li et al., 1999). By contrast, the
expression of IKKε is inducible and largely immune-cell specific,
as reflected in the observation that IKKε-deficient mice are viable
but hypersensitive to viral infection (Tenoever et al., 2007). IKKε-
deficient mice are also less prone to diet-induced obesity and
inflammation (Chiang et al., 2009).
Upon activation by Toll-like receptors (TLRs) or cytoplasmic
RIG-1-like receptors (RLRs), TBK1 and IKKε stimulate type I
IFN production via direct phosphorylation of IFN regulatory tran-
scription factor 3 (IRF3) and IRF7 (Chau et al., 2008). TLR-medi-
ated activation of TBK1 involves TRIF- or MYD88-dependent
pathways, whereas engagement of RLRs activates the mito-
chondrial adaptor MAVS, which facilitates TBK1/IKKε-mediated
activation of IRF3/7 and NF-kB. Recently, the adaptor protein
STING was found to play an essential role in the signalingCell Reports 3, 747–758, March 28, 2013 ª2013 The Authors 747
response to cytoplasmic double-stranded DNA (dsDNA),
promoting TBK1-specific activation of IRF3 as well as STAT6
(Chen et al., 2011; Ishikawa and Barber, 2008). TBK1 also plays
a role in mediating autophagy in response to intracellular bacte-
rial pathogens (Radtke et al., 2007; Thurston et al., 2009; Wild
et al., 2011). Thus, TBK1 and IKKε play essential roles in both
antiviral and antibacterial innate immunity.
In addition to their role in innate immunity, TBK1 and IKKε
contribute directly to cell transformation (Shen and Hahn,
2011). IKKε is a breast cancer oncogene that is amplified in
30% of breast cancers. In these cancers, IKKε-mediated activa-
tion of NF-kB signaling is required for transformation, at least in
part through phosphorylation of the tumor suppressor CYLD
(Boehm et al., 2007; Hutti et al., 2009) and TRAF2 (Shen et al.,
2012). In cancers dependent on KRAS signaling, RALB-medi-
ated activation of TBK1 promotes cell survival (Barbie et al.,
2009; Chien et al., 2006; Xie et al., 2011). These observations
highlight the potential of these two serine-threonine kinases as
therapeutic targets in cancer.
Although the IKK-related kinases exhibit partial homology to
the IKKa and IKKb kinases, they play distinct roles in both normal
and malignant physiology. Indeed, the kinase domain (KD) of
TBK1 shares only 35% sequence identity with that of the
canonical IKKs, and the scaffold/dimerization domain (SDD) is
quite divergent, with only 10% identity over 250 residues. To
understand the biochemical differences among these major
immune-signaling kinases, we have undertaken structural and
biochemical studies and described a high-resolution crystal
structure of nearly full-length TBK1 in complex with the small-
molecule inhibitors MRT67307 (Clark et al., 2011a) and BX795
(Clark et al., 2009). The structure reveals a dimeric assembly
that is stabilized by an extensive network of interactions among
the KD, ubiquitin-like domain (ULD), and SDD. The contacts that
stabilize the dimer are largely conserved in the close homolog
IKKε but not in the canonical IKK IKKb, which dimerizes in an
unrelated manner (Xu et al., 2011). In addition, the SDD in
TBK1 adopts a conformation very different from that recently
observed in the corresponding domain of IKKb (Xu et al.,
2011). We find that TBK1 undergoes K63-linked ubiquitination
at sites in the KD (Lys30) and SDD (Lys401). These modifications
require an intact dimer and in turn are required for TBK1 activa-
tion. Our data provide a structural foundation for understanding
TBK1 regulation and further dissecting the functional differences
observed between the canonical IKKs and the IKK-related
kinases TBK1 and IKKε.
RESULTS
Structure of TBK1
We crystallized and determined the structure of TBK1 (residues
1–657) in complex with inhibitors MRT67303 and BX795 at
resolutions of 2.4 A˚ and 2.5 A˚, respectively (see Table S1 for
crystallographic details). In addition, we refined a third structure
crystallized under different buffer conditions at a resolution of
3.3 A˚. To obtain protein in a homogeneous, nonphosphorylated
state amenable to crystallization, we expressed the kinase-dead
D135N mutant and truncated the C-terminal domain (CTD) Fig-
ure 1A). The crystal structure reveals an elongated dimer with748 Cell Reports 3, 747–758, March 28, 2013 ª2013 The Authorsa central stalk formed by the two SDDs, which run roughly
parallel to each other along the length of the dimer. The KD
and ULD interact with each other and with the SDD to form
a globular head at one end of the stalk (Figure 1B). As discussed
below, the KD and ULD also contribute to dimerization via
multiple contacts with the SDD of the opposite subunit in the
dimer. The SDD resembles a triple-helical coiled-coil and orga-
nizes the structure as a whole (Figures 1B and S1B). Two of
the SDD helices are continuous along the entire length of the
domain; the first spans residues 408–481(a1) and the third
spans residues 577–651(a3). The intervening segment is mostly
helical (a2a, a2b, and a2c) but is interrupted by two loop
segments that appear to accommodate the overall superhelical
twist of the domain. The ULD and KD associate primarily with
the first helix in the SDD (Figures 1C and 1E). The interactions
of the ULD are particularly extensive and largely hydrophobic.
The saddle-shaped surface formed by strands b1–b5 in the
ULD arch across the SDD at approximately its midpoint,
centered on Gly442. Phe380 in the ULD packs against Gly442,
which is conserved in both IKKs and IKK-related kinases
(Figure S1A). Additional ULD-SDD interactions are illustrated in
Figure 1C. The linker connecting the ULD and SDD adopts an
extended conformation and packs in a hydrophobic groove
between the first and third helices in the SDD (Figure 1D). The
extensive hydrophobic contact between the ULD and SDD and
the intervening linker suggest that these elements comprise
a fixed structural unit that is unlikely to dissociate or rearrange
in the context of TBK1 recruitment and activation. The kinase
C-lobe is also well anchored, but largely by polar interactions
with the SDD (Figure 1E) and ULD (Figure 1F). Structures
were recently reported for the isolated ULD (Li et al., 2012) and
KDs of TBK1 (Ma et al., 2012), and for a fragment containing
both the KD and ULD (Ma et al., 2012). A comparison with
these structures reveals essentially identical interdomain orien-
tations, indicating that the KD-ULD interaction is well defined
irrespective of scaffolding interactions with the SDD (Figures
S1C and S1D).
The TBK1 KD exhibits the conserved protein kinase architec-
ture consisting of N- and C-terminal lobes with the active site
cleft at the interface. In the present structures, the KD adopts
an inactive conformation, with the C-helix and key residue
Glu55 displaced from the active site (Figures 2A and S1C). The
loop that connects strand b3 to the C-helix is partially disor-
dered. Rotations of the C-helix are a regulatory feature of
many kinases, and a conserved glutamic acid in this helix makes
a key salt-bridge interaction with an active-site lysine residue
when the C-helix pivots into the inward, active position. In
some kinases, the nonphosphorylated activation loop plays
a role in maintaining the outward, inactive position of the
C-helix. This appears not to be the case in TBK1, as the activa-
tion loop is largely disordered in the present structure. The
most N-terminal portion of the activation loop, the DFG motif,
is well resolved, but the remainder of the loop (residues 160–
175) is not visible in the electron density map. TBK1 is activated
by phosphorylation of Ser172 in the activation loop, and a
comparison with the recently described structure of the
Ser172-phosphorylated KD shows that the activation loop is
indeed organized by phosphorylation (Ma et al., 2012) and
Figure 1. TBK1 Structure and Interdomain
Interactions
(A) The domain structure of TBK1 includes the KD,
ULD, SDD, and CTD. The linker connecting the
ULD and SDD is colored magenta and all domains
are colored as in the structural representations
presented here.
(B) Overall structure of the TBK1 dimer in complex
with MRT67307. The domains of the second
subunit in the dimer are colored dark blue (kinase),
orange (ULD), and tan (SDD). The compound is
shown in a stick representation (yellow).
(C) Interaction of the ULD with the a1 helix in the
SDD. Each of the five b strands of the ULD
contributes to the mostly hydrophobic interface.
(D) The linker segment (pink) that connects the
ULD and SDD packs into the SDD (green surface)
via mostly hydrophobic interactions.
(E) The largely polar interface between the KD and
SDD includes hydrogen bonds between Tyr564
and Glu100, Lys416 and Glu99, and Arg427 and
the carbonyl of Ser266.
(F) The ULD associates with the C-lobe of the KD.
Tyr325 in the ULD hydrogen bonds with Glu109
in the KD, and Lys323 in the ULD is positioned
to make favorable electrostatic interactions with
Glu109.
See also Figure S1.that Ser172 phosphorylation also promotes the active position of
the C-helix (Figure S1C).
Inhibitor Binding
The compound BX795 was developed as an inhibitor of the
kinase PDK1 (Feldman et al., 2005) and was later discovered
to potently inhibit TBK1 (Clark et al., 2009). The related
compound MRT67307 was developed as a more specific inhib-
itor of TBK1 (IC50 = 19 nM; Clark et al., 2011a). These
compounds share a common anilinopyrimidine core and bind
in a similar manner, with the pyrimidine and aniline nitrogen
atoms hydrogen bonding with the backbone amide and carbonyl
groups, respectively, of Cys89 in the ‘‘hinge’’ segment at the
edge of the ATP-binding cleft (Figures 2B and S2). The pyrimi-Cell Reports 3, 747–75dine and aniline rings are roughly
coplanar and in contact with Met142
and Gly92 on the floor of the nucleotide-
binding cleft. In MRT67307, the methyl-
morpholino substituent contacts Phe88
in the hinge, while the cyclobutyl group
located on the pyrimidine 4-substituent
packs between Asp157 in the DFG motif
and the P-loop residues Gly18 and
Val23 (Figure 2B). The lack of activity
of MRT67307 on the canonical IKKs
appears to stem from several structural
differences within the binding site; in
particular, Phe88 in TBK1 is replaced
with a tyrosine in IKKb (which would
interfere with the observed orientation of
the morpholino group), and Thr156 is re-placed with isoleucine (which would eliminate a water-mediated
hydrogen bond with the carbonyl in the inhibitor).
TBK1 Dimer Contacts Are Conserved and Required
for Signaling
The dimeric architecture of TBK1 appears to be critically impor-
tant for its function and is created by conserved interactions
involving each of its domains (Figures 3A and 3B). The crystallo-
graphic asymmetric unit contains a single copy of the TBK1 poly-
peptide chain, and the dimer lies on a 2-fold symmetry axis in the
P3221 space group. Examination of the crystal lattice reveals
a second possible dimer relationship in which the subunits could
associate via a ‘‘head-to-head’’ contact between the KDs to
yield an extremely elongated dimer (Figure S3A). Visualization8, March 28, 2013 ª2013 The Authors 749
Figure 2. Structure of the KD and Interac-
tions with MRT67307
(A) The kinase adopts an inactive conformation
with helix aC rotated out of the active site. The
activation loop is disordered (dashed line) beyond
the DFG motif (red).
(B) Detailed view of inhibitor interactions.
MRT67307 forms dual hydrogen bonds with the
amide and carbonyl groups of Cys89, as well as
a water-mediated hydrogen bond with Thr156.
Electron densities for the compound and the
structure of the BX795 complex are shown in
Figure S2.of the purified TBK1 protein by negative-stain electron micros-
copy (EM) confirms the side-by-side dimer interpretation
described here (Figures S3B andS3C). Analysis of the oligomeric
state of TBK1 in solution using size exclusion chromatography
multi-angle light scattering (SEC-MALS) showed that both the
full-length protein (residues 1–729) and the crystallized construct
are dimeric (Figure S3D). Thus the truncated CTD region, which
contains the binding site for TANK and other adaptors, is not
required for the structural integrity of the dimer.
The dimer is stabilized by contacts between the ULD and KD
with the SDD of the contralateral subunit (Figure 3A). Although
there is little direct contact between the SDDs in the 2.4 and
2.5 A˚ (form I) structures described here, we observed consider-
able interaction in an alternate crystal form obtained using 2-
methyl-2,4-pentanediol (MPD) rather than polyethylene glycol
(PEG) as a crystallization agent (form II crystals; Figures S3E
and S3F). The ULD contributes its ‘‘EGR’’ sequence (residues
355–357) to the dimer interface. In each of the ULDs, Glu355
forms a salt bridge with Arg444 and also hydrogen bonds with
the indole nitrogen of Trp445 in the SDD of the opposite subunit.
Gly356 packs against the dimer-related Gly356 residue, and
Arg357 forms a salt bridge with Asp452 in the contralateral
SDD (Figure 3A).
Both the N- and C-lobes of the KD participate in dimer
contacts with the SDD of the opposite subunit (Figure 3A). In
the N-lobe, a salt bridge is formed between Asp33 in the kinase
and Lys589 in the SDD. In the C-lobe, the b7-b8 turn contacts the
SDD of the opposing subunit. Although the dimer interactions do
not block the kinase active site, they do appear to ‘‘clamp’’ the
relative orientations of its N- and C-lobes. Because kinase
activity is thought to require flexibility between the lobes, this
arrangement is suggestive of an autoinhibited state of TBK1.
Therefore, we measured the specific activity of dimeric TBK1,
including both the full-length protein and a 1-657 construct
(Table S2). Both are highly active in vitro, with specific activity
similar to that of the isolated KD (residues 1–310), which ismono-
meric. The dimer interaction does not block activation loop
autophosphorylation in trans, and the Ser172-phosphorylated
protein is also dimeric (Figure S3D). These data indicate that
TBK1 activation does not involve dissociation of the dimer.
Furthermore, the similar N- and C-lobe orientations observed
in the activated KD (Figure S1C) suggests that the dimer interac-750 Cell Reports 3, 747–758, March 28, 2013 ª2013 The Authorstions of the KD proper could be largely maintained upon
activation.
Mapping of the evolutionary variation among vertebrate TBK1
and IKKε sequences onto the surface of the protein shows that
the dimer contacts are generally well conserved, indicating
that the dimer is functionally significant and that IKKε is very simi-
larly organized (Figure 3B). Residues involved in the N-lobe
contact are particularly highly conserved. We note also that the
N-lobe contact on the SDD is part of amore extensive conserved
surface that wraps onto the opposite face of the SDD; the
conservation of this surface is striking in contrast to the
remainder of the exposed surface of the SDD (Figure 3B, right
panel). We tested the importance of the dimer interaction
surfaces for TBK1 activation and signaling (Figure 3C). In the
ULD dimer interface, the E355A, R357A, and E355A/R357A
double mutation abrogated phosphorylation of TBK1 on
Ser172 as well as phosphorylation of IRF3. Mutations in the
kinase/SDD dimer interface also impaired TBK1 activation and
IRF3 phosphorylation (D33A in the KD; R547D and K589D in
the SDD). By contrast, mutation of kinase residue K251, which
is not involved in dimer formation, was without effect. Mutations
in each of the dimer contacts also impaired activation of both
IFN-stimulated response element (ISRE)- and NF-kB-activated
luciferase reporters (Figure 3D). Moreover, expression of these
mutants failed to induce expression of either RANTES (also
known as CCL5) or the direct IRF3 target gene IFNB1 (Figure 3D).
We also tested the dimer interfacemutants for their ability to form
dimers in vitro. The R547D and E355A/R357A mutants were
largely monomeric in solution (Figure 3E). However, the D33A
and E355A single-point mutations were not sufficient to disrupt
the dimer in vitro, at least at the relatively high protein concentra-
tions required for analysis by MALS. We further found that the
R547D and E355A/R357A mutants impaired dimer formation
in a cellular context as well, as assessed by coimmunoprecipita-
tion (co-IP) of Flag- and V5-tagged constructs expressed in
HEK293T cells (Figure 3F).
The larger conserved surface on the end of the SDD (including
residues Tyr577, Glu580, and Ile582) also appears to be required
for efficient IRF3 phosphorylation and expression of IFNB1 and
RANTES messenger RNA (mRNA; Figure 3G). Strikingly,
however, mutation of these residues does not impair TBK1 phos-
phorylation (Figure 3G). These residues are not involved in
dimerization or other interdomain contacts; thus, it will be of
interest to test directly the role of these surfaces in recognition
of TBK1 binding partners and substrates.
TBK1 and IKKb Differ in their Mode of Dimerization
and Quaternary Organization
TBK1 and IKKb are both dimers composed of sequential KD,
ULD, linker, and SDD domains, but the sequence and conforma-
tions of their SDDs are markedly divergent. Thus, their mode of
dimerization and overall quaternary organization are quite
different. Interestingly, superposition of the ULDs of TBK1 and
IKKb shows that both interact with the first long helix in the
SDD, centered on a glycine residue that is conserved in primary
sequence (Figure 4A). This superposition supports the notion
that the entire domain assembly of both TBK1 and IKKb share
a common evolutionary origin, and it also highlights the structural
divergence in the SDDs. Despite the observation that both
share a ‘‘down-up-down’’ topology of the three mostly helical
segments, their conformation is quite different and the domains
overall cannot be superimposed along their entire length (Fig-
ure S4). In IKKb, the end of the final helical segment in the SDD
mediates dimerization (Xu et al., 2011), whereas in TBK1 it is
the end of the first helical segment that contributes to the
SDD/SDD interface in the form II crystals (Figures S3F and
S4A). The divergence in the SDDs begets larger differences in
other domain interactions; the ULDs in IKKb extend away from
the SDD of the opposite subunit, while in TBK1 they bridge
between the two SDDs (Figure 4B).
K63-Linked Polyubiquitination of TBK1 on Lys30 and
Lys401 Is Required for TBK1 Activation and Signaling
In an accompanying paper in this issue of Cell Reports, Zhou
et al. (2013) show that K63-linked polyubiquitination of IKKε at
Lys30 and Lys401 is required for its catalytic activation. Mutation
of Lys30 and Lys401 blocks IKKε kinase function, NF-kB activa-
tion, and transformation. These modified lysine residues are
conserved in TBK1 (with identical residue numbers; Figure S1A).
Additionally, K63-linked polyubiquitination is required for viral
activation of IRF3 (Zeng et al., 2009), and TBK1 associates
with polyubiquitin-binding proteins such as optineurin (Gleason
et al., 2011). Thus, we determined whether TBK1 is similarly
modified by K63 polyubiquitination. We cotransfected
HEK293T cells with glutathione S-transferase (GST)-TBK1 and
either wild-type (WT) hemagglutinin (HA)-epitope-tagged ubiqui-
tin or an HA-tagged mutant ubiquitin that forms only K63-linked
chains. When we isolated GST immune complexes and looked
for HA-epitope tagged ubiquitin, we confirmed that TBK1 is
also modified by K63-linked ubiquitination (Figure 5A). This
ubiquitination does not require TBK1 activity, as WT and
a kinase-dead mutant TBK1 construct were similarly modified
(Figure 5B). Individual K30R and K401R point mutations ex-
hibited decreased TBK1 ubiquitination, and we failed to observe
ubiquitination of the TBK1 K30R/K401R double mutant
(Figure 5C).
We next examined the effect of dimer-disrupting mutations on
TBK1 ubiquitination. The E355A/R357D, R547D, and D33A
mutants exhibited markedly decreased K63-linked poly-
ubiquitination in HEK293T cells (Figure 5D). In contrast, theE355A and H459E/N474A mutants that retained the ability to
form dimers (Figure 3E) were still ubiquitinated. We also found
that the D33A mutant showed markedly decreased ubiquitina-
tion despite retaining the ability to form dimers in solution. We
note that Asp33 is proximal to the Lys30 ubiquitination site;
thus, this mutation may interfere with ubiquitination by affecting
recognition of the modification site.
We next tested the effect of point mutations in the ubiquitina-
tion sites on TBK1-driven gene expression and on TBK1 activa-
tion. Although the individual TBK1 K30R and K401R mutants
induced IFNB1 and RANTES mRNA levels to a similar degree
as WT TBK1, the TBK1 K30R/K401R mutant failed to induce
IFNB1 and RANTES mRNA levels (Figure 6A). Addition of the
‘‘phosphomimetic’’ S172E mutation did not bypass the require-
ment for ubiquitination, but this mutation was previously shown
to be ineffective in activating TBK1 (Kishore et al., 2002). Consis-
tent with their effects on IFNB1 and RANTES expression, we
observed that the single-point mutants retained constitutive
phosphorylation of Ser172, whereas the K30R/K401R double
mutant was not phosphorylated even when expressed at similar
levels (Figure 6B). It is unlikely that the K30R and K401R
mutations affect the folding or stability of TBK1, as both residues
are exposed on the surface of the dimer (Figure 6C). In addi-
tion, we note that the individual K30R and K401R mutants
retained activity and at least some degree of K63-linked poly-
ubiquitination, and also supported TBK1 phosphorylation (Fig-
ure 5C). We further observed that although dimerization and
K63-polyubiquitination mutants exhibited impaired TBK1 activa-
tion and signaling in cells, these mutants did not abolish TBK1
kinase activity in vitro (Figure S5).
To determine the requirements for dimerization and ubiquiti-
nation in a physiologic setting, we reconstituted TBK1/mouse
embryo fibroblasts (MEFs) with WT or mutant TBK1 constructs
and tested the effect of polyinosinic-polycytidylic acid (poly
I:C) stimulation on IFN-b expression (Figure 6D). Stimulation
increased IFNB1 mRNA levels in cells reconstituted with
WT TBK1 at 2 and 4 hr, as expected. This response was
ablated in cells reconstituted with the dimerization-defective
TBK1 mutants E355A/R357A and R547D, and in the K30R/
K401R polyubiquitination mutant (Figure 6D). We conclude that
like IKKε (Zhou et al., 2013), TBK1 undergoes K63-linked
polyubiquitination on conserved lysines 30 and 401. Poly-
ubiquitination on at least one of these two sites and dimer forma-
tion are required for phosphorylation of Ser172 in the kinase
activation loop and regulation of IRF-responsive genes.
DISCUSSION
TBK1 is engaged by a diversity of stimuli, yet how it is activated
in these contexts remains incompletely characterized. In the
setting of cytosolic dsDNA, STING acts as a scaffold that recruits
IRF3 and TBK1 to its C-terminal tail (Tanaka and Chen, 2012).
Oligomerization of STING and endoplasmic reticulum localiza-
tion upon cytosolic DNA detection recruits both TBK1 and
IRF3 and promotes TBK1 Ser172 phosphorylation, thereby facil-
itating specific activation of IRF3. A similar mechanismmay facil-
itate phosphorylation of STAT6 by TBK1 in the setting of antiviral
innate immunity (Chen et al., 2011). Recent work has alsoCell Reports 3, 747–758, March 28, 2013 ª2013 The Authors 751
Figure 3. Structure, Conservation, and Function of the TBK1 Dimer Interface
(A) Oblique view of the TBK1 dimer interface, highlighting interactions between the KD and ULD of one subunit and the SDD of the opposite subunit in the dimer
(tan). Hydrogen bonds that stabilize the dimer are indicated by dashed lines.
(B) Conservation among 43 vertebrate TBK1 and IKKε sequencesmapped onto the surface of TBK1. The inward, dimer-forming surface of TBK1 subunit is shown
on the left and the outward-facing surface is on the right. Contact points in the dimer interface are well conserved (yellow circles). Note the highly conserved
surface on the upper end of the SDD (surrounding Glu580). Analyses were performed with the CONSURF server (Ashkenazy et al., 2010).
(C) Expression of WT or mutant TBK1 in HEK293T cells following transient transfection of the indicated dimer contact mutants. TBK1 protein levels, Ser172
phosphorylation, and total and Ser396 phospho-IRF3 were analyzed by immunoblotting 60 hr posttransfection. The K38M mutant is a kinase-inactive positive
(legend continued on next page)
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Figure 4. Comparison of the TBK1 and IKKb
(A) Superposition of TBK1 with IKKb (magenta).
Structures are superimposed using the ULD,
which highlights the general similarity in the
manner in which the ULD anchors the KDs to the
SDD in both proteins. This structural alignment
also superimposes a glycine residue (black dot) in
the ULD/SDD interface (Gly442 in TBK1 and
Gly450 in IKKb) that is conserved in both proteins
and occurs in the same position in their primary
sequences despite the overall divergence in their
SDDs (see also Figures S4E and S4F). Note also
that the orientation of the KDs in the two structures
is quite different relative to the ULD and SDD.
(B) Surface views of TBK1 (top panels) and IKKb
(lower panels), with corresponding domains of
IKKb colored as in TBK1. In TBK1, the ULDs bridge
between dimer-related SDDs, whereas in IKKb
they extend away from the opposite SDD. Like-
wise, the KDs in IKKb are differently oriented and
do not form dimer contacts. The IKKb structure
is drawn from Protein Data Bank ID code 3QA8
(Xu et al., 2011).demonstrated that viral infection and RLR-mediated MAVS
activation induces large functional aggregates on the mito-
chondrial membrane that involve K63-linked polyubiquitination
and recruitment of TRAF2 and TRAF6 (Hou et al., 2011). Recruit-
ment of NEMO to these MAVS complexes may bind TANK and
TBK1 to promote its activation (Zeng et al., 2009). A similar
model was proposed for MYD88-dependent TBK1 activation
that occurs downstream of interleukin-1 or specific TLRs (Clark
et al., 2011b). In this setting, K63-linked polyubiquitin chains
formed by TRAF6 are proposed to recruit a complex including
NEMO and TANK that links TAK1 and the canonical IKK complex
to TBK1/IKKε Ser172 phosphorylation and activation.
In addition to these recruitment models, direct K63-linked
polyubiquitination of TBK1 by TRAF3, NDRP1, or MIB1 E3
ligases may be involved in its innate immune-mediated activa-
tion of TBK1 (Li et al., 2011; Parvatiyar et al., 2010; Wang
et al., 2009). CYLD-mediated deubiquitination of TBK1 has
also been shown to inhibit the TBK1-driven IRF3 response
(Friedman et al., 2008). A recent report identified Lys69,
Lys154, and Lys372 as K63-linked polyubiquitination sites in
TBK1 (Wang et al., 2012). From a structural perspective, two ofcontrol and K251A is a negative control mutation that is remote from the dimer
transfection. The mean and SE of triplicate samples are shown.
(D) EGFP control-normalized values for mRNA levels of INFB1 and RANTES (up
posttransfection of WT or mutant TBK1 constructs. Reporter activity was meas
standardized. For qRT-PCR the mean and SE of triplicate samples are shown. R
(E) SEC-MALS analysis of TBK1 dimer interface mutants. Purified TBK1 dimer int
column coupled to aMALS detector. All proteins analyzed contain the D135N cata
asmeasured by refractive index are shown. The labeled horizontal traces indicate
of a dimer is 152.2 kDa), and 86.9 kDa for E355A/R357A and 95.1 kDa for R
protein and their molar masses are also similar.
(F) Immunoblot of WCEs (lower panels) or FLAG IP (upper panels) following trans
TBK1-R547D constructs as indicated. Arrow indicates the specific band represe
(G) Conserved SDD patch mutants were expressed in 293T cells and analyzed fo
levels, and IFNB1 and RANTES expression.
See also Figure S3 for further analysis of the dimer. The mean and SE of triplicatthese sites appear unlikely to represent regulatory modification
sites. Lys154 forms key structural interactions and is near-
universally conserved among all protein kinases. Mutation or
modification of this residue can be expected to disrupt the fold
of the KD. Lys372 is among the most variable residues in verte-
brate TBK1 and IKKε sequences, and access to this residue
appears to be impeded in the TBK1 dimer. Lys69, however, is
relatively exposed for modification and lies near the Lys30 and
Lys401 sites we have identified. In the accompanying paper,
Zhou et al. (2013) dissect the essential role of K63-linked poly-
ubiquitination in regulating IKKε in the context of both cell trans-
formation and immune signaling. Interestingly, the two essential
residues for IKKε K63-linked polyubiquitination, Lys30 and
Lys401, are conserved with TBK1. We demonstrate here that
K63-linked polyubiquitination of TBK1 at Lys30 and Lys401 is
essential for its downstream activity. Our structural work reveals
that these two residues are found on opposing faces of the TBK1
monomers but are in close proximity in the context of the catalyt-
ically active TBK1 dimer (Figure 6C). Furthermore, mutation of
both sites disrupts signaling to IFN-b following TBK1 overex-
pression in HEK293T cells, or upon poly I:C stimulation ininterface. qRT-PCR for TBK1 mRNA expression was performed 48 hr post-
per panel) or ISRE and NF-kB luciferase reporter activity (lower panels) 48 hr
ured in tandem with a control renilla luciferase vector to which values were
eporter assays were performed in replicates of 64; mean and SD are shown.
erface mutants and WT protein were analyzed on a Superdex 200 gel filtration
lytic site mutation because it can be expressed abundantly. The elution profiles
themeasuredmolar mass:146.3 kDa for TBK1WT (the expectedmolar mass
547D. D33A, E355A, and H459E/N474A elute at the same position as the WT
ient transfection of FLAG- and V5-tagged TBK1-WT, TBK1-E355A/R357A, or
nting V5-TBK1.
r total and phospho-TBK1 levels, total and phospho-IRF3 levels, TBK1 mRNA
e samples are shown.
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Figure 5. TBK1 Is Modified by K63-Linked Polyubiquitin Chains
(A) TBK1 is K63-linked polyubiquitinated. HA-tagged WT or K63-only ubiquitin cells were cotransfected with GST-TBK1 into HEK293T cells. GST immune
complexes (TBK1) were isolated, followed by immunoblotting with the indicated antibodies; 5% of the whole cell lysate was loaded for comparison (input).
(B) WT and kinase-dead TBK1 are ubiquitinated equally. HA-tagged K63-only ubiquitin cells were cotransfected with WT and kinase-dead GST-TBK1 into
HEK293T cells. GST immune complexes (TBK1) were isolated followed by immunoblotting with the indicated antibodies; 5% of the whole-cell lysate was loaded
for comparison (input).
(C) TBK1 undergoes K63-linked polyubiquitination at Lys30 and Lys401. HEK293T cells were transfected as indicated. V5 immune complexes (TBK1) were
isolated, followed by immunoblotting with the indicated antibodies; 5% of the whole-cell lysate was loaded for comparison (input).
(D) TBK1 dimer-deficient mutants do not undergo K63-linked ubiquitination. HEK293T cells were transfected as indicated. V5 immune complexes (TBK1) were
isolated, followed by immunoblotting with the indicated antibodies; 5% of the whole-cell lysate was loaded for comparison (input).TBK1 null MEFs. TBK1 Ser172 phosphorylation is also disrupted
in the K30R/K401R mutant, suggesting that ubiquitination is
directly required for TBK1 activation in a cellular milieu.
Themechanistic role of K63-linked ubiquitination at these sites
remains to be fully elucidated. The active sites of the two KDs lie
on opposite faces of the TBK1 dimer, and therefore the isolated
dimer cannot autoactivate. Thus K63-linked ubiquitination may
regulate recruitment of another kinase that promotes Ser172
phosphorylation, and it may promote assembly of TBK1 into
higher-order complexes that allow its autoactivation in trans. In
support of this model, NEMO has been shown to bind to polyu-
biquitinated TBK1 via its ubiquitin-binding domains (Wang et al.,
2012). Furthermore, TBK1 binds the NEMO-related protein opti-
neurin as well as the adaptor NDP52, both of which recognize
K63-linked polyubiquitinated proteins (Morton et al., 2008; Thur-
ston et al., 2009; Wild et al., 2011). Mutation of the ubiquitin
recognition domain of optineurin impairs activation of TBK1 in
response to the TLR agonists LPS and polyI:C (Gleason et al.,754 Cell Reports 3, 747–758, March 28, 2013 ª2013 The Authors2011). Although a polyubiquitin-dependent recruitment or clus-
tering mechanism appears to be an essential component of
TBK1 activation, we cannot rule out the possibility that ubiquiti-
nation could also play an allosteric role by releasing or modifying
intramolecular contacts of the kinase N- and C-lobes to promote
TBK1 activation.
Taken together, these observations reveal a multistep mecha-
nism for TBK1 activation in which K63-linked polyubiquitination
is a prerequisite for kinase activation by Ser172 phosphorylation
in cells. The dimeric, multidomain architecture of TBK1 is critical
for orchestrating these regulatory events and for subsequent
phosphorylation of IRF3. Dimer interface mutations in the KD
(D33A), ULD (E355A/R357A), or SDD (R547D) block K63-linked
polyubiquitination and thus also prevent Ser172 phosphoryla-
tion. Our biophysical characterization of the monomeric pro-
teins shows that they are not simply misfolded, and we find
that even the isolated (monomeric) KD retains kinase activity
in vitro. It is unclear whether kinase activation is the only role of
Figure 6. K63-Linked Polyubiquitination Is Required for TBK1-
Induced Gene Expression and Kinase Activation
(A) mRNA levels of INFB1 andRANTESweremeasured by qRT-PCR30 hr after
transient transfection of the indicated ubiquitination site mutants and
normalized to control EGFP-transfected cells. The mean and SE of triplicate
samples are shown.
(B) Immunoblot showing total TBK1 and Ser172 phospho-TBK1 levels 48 hr
posttransfection of the indicated constructs.
(C) Locations of Lys30 and Lys401 ubiquitination mapped on the TBK1
structure. One TBK1 monomer is in green and the other is in cyan. Note
that Lys401 from monomer ‘‘a’’ is close to Lys30 of monomer ‘‘b’’ across the
dimer interface.polyubiquitination, because the S172E phosphomimetic mutant
does not effectively activate TBK1 (Kishore et al., 2002). In addi-
tion to its roles as a mediator of dimer formation and a site of
polyubiquitination, the SDD is also required for proper substrate
phosphorylation in cells—the conserved surface surrounding
Glu580 is required for IRF3 phosphorylation and reporter activa-
tion, despite the fact that it is dispensable for TBK1 activation
per se. The SDD is not required for efficient IRF3 phosphorylation
in vitro, because the isolated KD and intact TBK1 phosphorylate
IRF3 with similar kinetics (Ma et al., 2012). We speculate that
this surface may be a site of interaction with a substrate-recruit-
ing adaptor such as STING (Tanaka and Chen, 2012).
The conserved Glu580 surface of the TBK1 SDD domain, as
well as its dimer contacts and polyubiquitination sites, is
preserved in IKKε but not in IKKa and IKKb. Furthermore, the
SDD- and ULD-mediated contacts with the N- and C-lobes of
the kinase are not found in the IKKb structure, which dimerizes
in an essentially unrelated manner. Although the canonical
IKKs and the IKK-related kinases TBK1 and IKKε share some
homology, the dramatic structural divergence between these
classes of IKKs reflects their different biology and regulation.
Indeed, although TBK1 and IKKε were discovered vis-a`-vis their
intersections with NF-kB signaling, it is becoming increasingly
clear that many of their major functions are quite distinct from
this pathway and from those of canonical IKKs. The present
data provide a structural foundation for understanding the regu-
lation and interactions of both TBK1 and IKKε, and for further
dissecting the participation of TBK1 in diverse processes such
as viral clearance, autophagy (Weidberg and Elazar, 2011; Wild
et al., 2011), and survival of KRAS-dependent cancers (Barbie
et al., 2009; Ou et al., 2011; Xie et al., 2011). Additionally, the
structures described here will facilitate the development of
small-molecule inhibitors that may be useful as anticancer or
anti-inflammatory agents.
EXPERIMENTAL PROCEDURES
Expression Constructs
The pCMV6-XL5-TBK1-WT and pCMV6-XL5-TBK1-K38M constructs were
purchased from Origene and PCR subcloned into the pLEX980 vector using
Gateway technology. Sequencing of pLEX980-TBK1-WT and pLEX980-
TBsK1-K38M confirmed that these sequences were correct. TBK1 mutants
of the pLEX980-TBK1-WT construct were generated by standard PCR muta-
genesis, Gateway cloned back into the pLEX980 or the closely related
pLEX304 vector, and sequence verified. HA-ubiquitin and HA-Ub K63-only
constructs were used as previously described (Abbott et al., 2004; Boehm
et al., 2007).
Protein Expression, Purification, and Crystallization
Constructs spanning residues 1–310, 1–657, or the full length (1–729) of human
TBK1 bearing the WT sequence or D135N mutation were expressed as 6xHis
plus GST fusion proteins in Hi5 insect cells using the pTriEx transfer vector
(Novagen) and BacVector-3000 Baculoviral DNA (Novagen). Details regarding
purification by nickel-nitrilotriacetic acid (Ni-NTA) and glutathione sepharose(D) qRT-PCR measurement of IFNB1 and TBK1 mRNA following TBK1
reconstitution in TBK1/ MEFs and stimulation with poly I:C. Cells were
nucleofected with EGFP control or the indicated TBK1 constructs, and 24h
later were stimulated with 100 mg/ml poly I:C for 0 hr, 2 hr, or 4 hr. The mean
and SE of triplicate samples are shown.
See also Figure S5.
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chromatography are given in Extended Experimental Procedures. The
TBK1(1-657) D135N protein was concentrated to 8 mg/ml for crystallization.
MRT67307 or BX-795 was added to the TBK1 protein solution to 0.25 mM
immediately prior to crystallization. Crystals of form I were obtained in 4%
(w/v) PEG8000 and 100 mM Tris pH 8.7. Crystals of form II grew in 5% MPD
and 100 mM HEPES pH 7.5. The SeMet TBK1 protein was crystallized at
7 mg/ml with BX795 added to 0.5 mM in hanging drops over a reservoir con-
taining 5% PEG6000, 2.5% MPD, 100 mM HEPES pH 7.5, and 10 mM TCEP.
Structure Determination
The structure was determined by single-wavelength anomalous diffraction
(SAD) phasing with a 3.65 A˚ SeMet derivate data set collected on the NE-
CAT beamline at Argonne National Laboratory. The TBK1/BX795 structure
was refined to a final R value of 19.7% (Rfree = 25.5%) at 2.5 A˚ resolution,
and the TBK1/MRT67307 structure was refined to a final R value of 19.9%
(Rfree = 23.6%) at 2.4 A˚ resolution. The form II crystal structure was refined
to an R value of 22% (Rfree = 27.9%) at 3.3 A˚ resolution. Crystallographic
data collection and refinement statistics are presented in Table S1 and further
details regarding structure determination and refinement are provided in
Extended Experimental Procedures.
In Vitro Enzyme Kinetics and Other Biophysical Studies
Kinase assays were carried out in triplicate using the ATP/NADH coupled
assay system in a 96-well format as previously described (Yun et al., 2007).
Further details and experimental procedures for IP kinase assays, in vitro
phosphorylation of kinase-dead TBK1 proteins, SEC-MALS, and EM are
provided in Extended Experimental Procedures.
Reporter Assays and Quantitative RT-PCR
HEK293T cells were seeded in six-well plates at 73 105 cells/well and reverse
transfected using Fugene 6 Reagent. Cells were transfected with 1 mg
pLEX980-EGFP, pLEX980-TBK1-WT, TBK1-K38M, or the indicated TBK1
mutants together with 500 ng NFkB(1) Firefly luciferase reporter vector (Pano-
mics) or 500 ng ISRE Firefly luciferase reporter vector (Panomics), and 500 ng
pRL-TK Renilla luciferase control vector. At 24 hr posttransfection, the cells
were trypsinized and seeded at a density of 2,500 cells/well in 384-well plates,
with 64 replicate wells per condition. At 48 hr posttransfection, luciferase
activity wasmeasured using the Dual-Glo Luciferase Assay System (Promega)
or RNA was prepared for quantitative RT-PCR (qRT-PCR) as described in
Extended Experimental Procedures.
Immunoblotting/Antibodies
Lysates were prepared 60 hr after transient transfection of HEK293T cells with
TBK1 constructs using standard RIPA buffer. Immunoblotting was performed
as previously described (Barbie et al., 2009). Antibodies were obtained from
Cell Signaling Technology (anti-TBK1 #3013, anti-phospho-TBK1 Ser172
#5843), Santa Cruz (anti-iRF3 #sc-9082), Millipore (anti-phospho-IRF3 Ser
396), and HA (Clone12C5; Boehringer Mannheim). Anti-V5 affinity gel sephar-
ose was obtained from Sigma-Aldrich and glutathione affinity gel sepharose
was obtained from GE Healthcare. Membranes were developed using both
the Odyssey Infrared Imaging System (LICOR) and traditional enhanced-
chemiluminescence-based detection.
Dimer IP
N-terminal FLAG and C-terminal V5-tagged pLEX-TBK1-WT, pLEX-TBK1-
E355A/R357A, and pLEX-TBK1-R547D constructs were transiently trans-
fected into HEK293T cells, and 48 hr later the cells were lysed in RIPA buffer.
FLAG IP was performed in RIPA buffer using FLAG-conjugated agarose beads
(Sigma). Immunoblotting of whole-cell extracts (WCEs) and immunoprecipi-
tated material was performed with a mouse anti-FLAG antibody (Sigma) or
mouse anti-V5 antibody (Invitrogen).
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